As proposed in Fig. 8, our data demonstrated that ARRB2 could functionally inhibit TRAF6-TAB2 signaling and TRAF6-BECN1 signaling for coordinating lung cancer progression through NF-κB activation and autophagy, respectively. Here, TAB2 is linked to lung cancer.